This product has been assayed against 1.0 ug of Human IgG in a standard capture ELISA using Peroxidase Conjugated Streptavidin S000-03 and ABTS (2,2-azino-bis-[3-ethylbenthiazoline-6-sulfonic acid]) code ABTS-100 as a substrate for 30 minutes at room
IgG responses to SARS-CoV-2 N protein variants. Four SARS-CoV-2 N protein variants were fabricated on to the microarray surface, including full-length N protein, core domain (amino acids 44-364), C-terminal domain (CTD) (amino acids 248-365) and N terminal domain (NTD) (amino acids 24-181). The IgG response from the plasma of 8 colorectal cancer (C) and 7 convalescent COVID-19 (P) patients were assessed for the 4 variants. Figure S5. PMID: 33925055.
Linearity of signal as a function of serum dilution on the microarray platform. Panels A & B show data for the N core domains, N-terminal domain and C-terminal domain, for patients 189 and 192 respectively. Panels C & D show data for peptides 6, 8 & 16, for patients 189 and 192 respectively. x-axis shows the serum dilutions for each measurement. y-axis units are relative fluorescence units (RFU). Figure S4. PMID: 33925055.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten